Bufalin Inhibits HCT116 Colon Cancer Cells and Its Orthotopic Xenograft Tumor in Mice Model through Genes Related to Apoptotic and PTEN/AKT Pathways

Table 2

Survival time of mice with xenograft tumor.

Group		Median survive (day)	95% CI	(compare to control)
NS	6	40	35.2–44.8	—
5-FU	6	37	33.9–40.2	>0.05
BL	6	47	43.6–50.4	<0.05
BM	6	46	42.6–49.4	<0.05
BH	6	45	35.9–54.1	<0.05

Note. BL: Bufalin low dose group; BM: Bufalin median dose group; BH: Bufalin high dose group.
95% confidence interval.